Skip to content

Medical Devices; Anesthesiology Devices; Classification of the Spinal Imaging System for Neuraxial Procedures

Final rule · Federal Register document 2026-22181

Published
10/30/2026
Effective
10/30/2026
Pages
3

Summary

Final amendment; final order.

The Food and Drug Administration (FDA) is classifying the spinal imaging system for neuraxial procedures into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the spinal imaging system for neuraxial procedures. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

Read the official textPDF on GovInfo

Details

Type
Final rule
Docket
Docket No. FDA-2026-N-12255
CFR parts
21 CFR 868
Topics
Medical devices

This page summarizes a Federal Register document. Only the official Federal Register text has legal effect. Comment deadlines can be extended or reopened by a later notice.

Source: Office of the Federal Register, via the Federal Register API · Last updated 10/30/2026

Share: